Norepinephrine receptor

Norepinephrine receptors—more accurately termed adrenergic receptors—are a family of G protein-coupled receptors that mediate the physiological actions of the catecholamine neurotransmitter and hormone norepinephrine. These are subdivided into two main classes based on their pharmacology and function: • Alpha-adrenoceptors (α-adrenergic): further divided into α1 (α1A, α1B, α1D) and α2 (α2A, α2B, α2C) subtypes. They regulate vascular tone, neurotransmitter release, sedation/analgesia, blood pressure control, cognitive functions like working memory and attention in the prefrontal cortex. • Beta-adrenoceptors (β-adrenergic): include β1, β2, and β3 subtypes. They are involved in cardiac stimulation (inotropy/chronotropy via β1), bronchodilation (β2), lipolysis (β3), among other roles. Adrenergic drugs target these receptors for therapeutic purposes across a wide range of indications including shock states (vasopressors like norepinephrine itself), heart failure/hypertension management (blockers/antagonists), asthma/COPD therapy (β2 agonists like albuterol). Dysregulation or altered expression/function is implicated in diseases ranging from depression/schizophrenia to cardiovascular disorders. The term "Norepinephrine receptors" is not the canonical name; the scientifically accurate term is "Adrenergic receptor" or "Adrenoceptor." There are multiple subtypes rather than a single entity called “norepinephrine receptor.” Therefore, it refers generically rather than specifically to any one molecular target/family member.

Other names

Adrenergic receptorAdrenoceptorNoradrenaline receptorAlpha-adrenergic receptorBeta-adrenergic receptor

- Agonists stimulate adrenergic receptors to mimic or enhance norepinephrine signaling. - Antagonists block adrenergic receptors to inhibit norepinephrine effects. - Reuptake inhibitors increase synaptic norepinephrine by blocking its reabsorption into neurons.